141 related articles for article (PubMed ID: 8899801)
21. Effect of hypergastrinemia on pancreatic carcinogenesis.
McDonald JM; Longnecker DS; Bell RH
Am J Surg; 2002 Apr; 183(4):441-4. PubMed ID: 11975934
[TBL] [Abstract][Full Text] [Related]
22. Growth of pancreatic foci and development of pancreatic cancer with a single dose of azaserine in the rat.
Roebuck BD; Baumgartner KJ; Longnecker DS
Carcinogenesis; 1987 Dec; 8(12):1831-5. PubMed ID: 3499996
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cholecystokinin receptors in rat pancreas. Evidence for expression of CCK-A receptors but not CCK-B (gastrin) receptors.
Zhou W; Povoski SP; Rosen NA; Longnecker DS; Bell RH
Ann N Y Acad Sci; 1994 Mar; 713():331-3. PubMed ID: 8185179
[No Abstract] [Full Text] [Related]
25. Visualization and characterization of CCK receptors in exocrine pancreas of rat with storage phosphor autoradiography.
Tang C; Biemond I; Lamers CB
Pancreas; 1996 Oct; 13(3):311-5. PubMed ID: 8884854
[TBL] [Abstract][Full Text] [Related]
26. Histochemical studies on gamma-glutamyltranspeptidase activity of pancreatic acinar cell lesions induced by 4-hydroxyaminoquinoline 1-oxide and/or azaserine in rats.
Murata Y; Denda A; Obara T; Yokose Y; Konishi Y
Exp Pathol; 1987; 32(1):41-53. PubMed ID: 2889612
[TBL] [Abstract][Full Text] [Related]
27. Ulex Europaeus-I: a marker for differentiation of (pre)cancerous lesions induced in the rat pancreas by azaserine.
Takiyama Y; Woutersen RA; Pour PM
Carcinogenesis; 1988 Nov; 9(11):2087-92. PubMed ID: 3180343
[TBL] [Abstract][Full Text] [Related]
28. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.
Roebuck BD; Kaplita PV; Edwards BR; Praissman M
Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by azaserine in Wistar rats.
Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
Cancer Lett; 1996 Jul; 105(1):23-7. PubMed ID: 8689627
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine inhibition of azaserine-induced atypical acinar cell foci in rat pancreas.
Shinozuka H; Roebuck BD; Longnecker DS
Pancreas; 1990 Jul; 5(4):389-93. PubMed ID: 2381899
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine.
Sumi C; Longnecker DS; Roebuck BD; Brinck-Johnsen T
Cancer Res; 1989 May; 49(9):2332-6. PubMed ID: 2706621
[TBL] [Abstract][Full Text] [Related]
32. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
Appel MJ; Meijers M; Van Garderen-Hoetmer A; Lamers CB; Rovati LC; Sprij-Mooij D; Jansen JB; Woutersen RA
Br J Cancer; 1992 Jul; 66(1):46-50. PubMed ID: 1637675
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
[TBL] [Abstract][Full Text] [Related]
35. A single-dose protocol for azaserine initiation of pancreatic carcinogenesis in the rat.
Yager JD; Roebuck BD; Zurlo J; Longnecker DS; Weselcouch EO; Wilpone SA
Int J Cancer; 1981 Nov; 28(5):601-6. PubMed ID: 6975760
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Jensen RT; Mantey SA; Bell RH
Gastroenterology; 1994 Oct; 107(4):1135-46. PubMed ID: 7523219
[TBL] [Abstract][Full Text] [Related]
37. Effects of corn oil and benzyl acetate on number and size of azaserine-induced foci in the pancreas of LEW and F344 rats.
Longnecker DS; Roebuck BD; Curphey TJ; Lhoste E; Coon CI; MacMillan D
Environ Health Perspect; 1986 Sep; 68():197-201. PubMed ID: 3490965
[TBL] [Abstract][Full Text] [Related]
38. Increased immunoreactivity and protein tyrosine kinase activity of the protooncogene pp60c-src in preneoplastic lesions in rat pancreas.
Visser CJ; Rijksen G; Woutersen RA; De Weger RA
Lab Invest; 1996 Jan; 74(1):2-11. PubMed ID: 8569183
[TBL] [Abstract][Full Text] [Related]
39. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
40. Secretagogue response of azaserine-induced rat pancreatic acinar tumors in vivo.
Herzig KH; Creutzfeldt W; Fölsch UR
Gastroenterology; 1991 Jul; 101(1):220-7. PubMed ID: 1710588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
